Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06489782 · ClinicalTrials.gov registry record · NA

Developing a Novel Human Laboratory Paradigm for AUD Medication Screening

A NA study of Alcohol Use Disorder, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT06489782 is a NA study of Alcohol Use Disorder that is actively recruiting participants, run by Yale University. The registered enrollment target is 90 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06489782, a NA study of Alcohol Use Disorder, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The intent of the study is to develop two versions of the 'ability to resist' drinking model designed to screen Alcohol Use Disorder (AUD) medications.

Conditions Studied

Interventions

  • OTHER Model 1
  • OTHER Model 2

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-11-01
Est. Completion 2026-06-30
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT06489782

The ClinicalTrials.gov registry entry for NCT06489782 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (73% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Model 1 is the first listed.

NCT06489782 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06489782 about?

NCT06489782 is a clinical study titled "Developing a Novel Human Laboratory Paradigm for AUD Medication Screening". The intent of the study is to develop two versions of the 'ability to resist' drinking model designed to screen Alcohol Use Disorder (AUD) medications.

What is the current status of trial NCT06489782?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-11-01. Estimated completion is 2026-06-30.

What conditions does trial NCT06489782 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT06489782?

The interventions under investigation include: Model 1 (OTHER), Model 2 (OTHER).

Who is sponsoring clinical trial NCT06489782?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06489782 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.